Health Care [ 4/12 ] | Health Care Equipment & Supplies [ 49/73 ]
NASDAQ | Common Stock
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally.
The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface.
It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy.
The company sells its products to end-users through the pharmacy channel; and independent distributors.
Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 7, 25 | 1.02 Increased by +39.73% | 0.77 Increased by +33.21% |
| Feb 20, 25 | 1.15 Decreased by -17.86% | 1.02 Increased by +12.63% |
| Nov 7, 24 | 0.90 Increased by +26.76% | 0.76 Increased by +18.42% |
| Aug 8, 24 | 0.55 Increased by +44.74% | 0.56 Decreased by -1.79% |
| May 9, 24 | 0.73 Increased by +217.39% | 0.39 Increased by +87.18% |
| Feb 22, 24 | 1.40 Increased by +483.33% | 0.66 Increased by +112.12% |
| Nov 2, 23 | 0.71 Increased by +102.86% | 0.40 Increased by +77.50% |
| Aug 8, 23 | 0.38 Increased by +176.00% | 0.26 Increased by +46.15% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 25 | 569.00 M Increased by +28.82% | 35.40 M Decreased by -31.26% | Increased by +6.22% Decreased by -46.64% |
| Dec 31, 24 | 597.50 M Increased by +17.20% | 100.70 M Decreased by -2.52% | Increased by +16.85% Decreased by -16.83% |
| Sep 30, 24 | 543.90 M Increased by +25.70% | 77.50 M Increased by +49.33% | Increased by +14.25% Increased by +18.80% |
| Jun 30, 24 | 488.50 M Increased by +23.20% | 188.60 M Increased by +590.84% | Increased by +38.61% Increased by +460.74% |
| Mar 31, 24 | 441.70 M Increased by +23.35% | 51.50 M Increased by +116.39% | Increased by +11.66% Increased by +75.43% |
| Dec 31, 23 | 509.80 M Increased by +37.90% | 103.30 M Increased by +507.65% | Increased by +20.26% Increased by +340.66% |
| Sep 30, 23 | 432.70 M Increased by +26.97% | 51.90 M Increased by +1.10 K% | Increased by +11.99% Increased by +886.10% |
| Jun 30, 23 | 396.50 M Increased by +32.43% | 27.30 M Increased by +178.00% | Increased by +6.89% Increased by +158.90% |